MoonLake Immunotherapeutics
NASDAQ:MLTX
51.78 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||
| Current Assets: | ||||||||||||||||
| Cash & Cash Equivalents
| 375.656 | 342.791 | 458.441 | 451.169 | 318.166 | 501.787 | 50.129 | 39.506 | 41.205 | 92.708 | 101.023 | 8.039 | 1.029 | 1.098 | 1.17 | 0 |
| Short Term Investments
| 118.268 | 177.008 | 88.614 | 59.839 | 177.813 | 0 | 12.921 | 32.609 | 42.255 | 0 | 0 | 0 | 0 | 0 | 115.015 | 0 |
| Cash and Short Term Investments
| 493.925 | 519.8 | 547.055 | 511.008 | 495.979 | 501.787 | 63.05 | 72.115 | 83.459 | 92.708 | 101.023 | 8.039 | 1.029 | 1.098 | 1.17 | 0 |
| Net Receivables
| 2.407 | 1.677 | 1.496 | 1.057 | 0.721 | 0.62 | 0.378 | 0.217 | 0.601 | 0.557 | 15 | 0.149 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 15.984 | 15.406 | 5.039 | 2.102 | 3.31 | 3.96 | 3.076 | 4.179 | 4.479 | 5.113 | 0.136 | 1.449 | 0.178 | 0.234 | 0.29 | 0 |
| Total Current Assets
| 512.316 | 536.882 | 553.59 | 514.167 | 500.01 | 506.367 | 66.504 | 76.511 | 88.539 | 98.378 | 116.159 | 9.637 | 1.207 | 1.331 | 1.46 | 0 |
| Non-Current Assets: | ||||||||||||||||
| Property, Plant & Equipment, Net
| 3.833 | 3.867 | 4.208 | 3.949 | 0.209 | 0.254 | 0.292 | 0.332 | 0.053 | 0.056 | 0.059 | 0.046 | 0.03 | 0 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 115.051 | 115.043 | 115.04 | 115.039 | 115.033 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 2.065 | 4.129 | 6.319 | 8.423 | 0 | 0 | 0 | -0 | 0 | 0 | -0.059 | -115.043 | -0.03 | 0 | 0 | 0 |
| Total Non-Current Assets
| 5.897 | 7.996 | 10.527 | 12.373 | 0.209 | 0.254 | 0.292 | 0.332 | 0.053 | 0.056 | 115.051 | 0.046 | 115.04 | 115.039 | 115.033 | 0 |
| Total Assets
| 518.213 | 544.878 | 564.117 | 526.54 | 500.219 | 506.621 | 66.797 | 76.843 | 88.592 | 98.434 | 231.21 | 9.682 | 116.247 | 116.37 | 116.492 | 0 |
| Liabilities & Equity: | ||||||||||||||||
| Current Liabilities: | ||||||||||||||||
| Account Payables
| 0 | 0.056 | 1.63 | 0.553 | 0.824 | 0.271 | 0.511 | 0.255 | 0.68 | 0.649 | 0.213 | 1.428 | 0.096 | 0 | 0 | 0 |
| Short Term Debt
| 1.445 | 1.322 | 1.304 | 1.198 | 0.156 | 0.158 | 0.155 | 0.154 | 0 | 0 | 15.15 | 15 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0.619 | 0.851 | 0.368 | 2.714 | 0 | 0.201 | 0.11 | 0.062 | 1.559 | 0 | 0.064 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0.563 | -0.778 | -0.185 | 0 | -0.271 | 0 | 0 | 0 | 0 | -0.213 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 18.636 | 10.341 | 6.755 | 8.4 | 9.328 | 6.976 | 6.614 | 7.257 | 5.339 | 3.208 | 187.64 | 4.659 | 1.963 | 0.09 | 0.06 | 0 |
| Total Current Liabilities
| 20.081 | 12.282 | 8.911 | 9.966 | 10.308 | 7.135 | 7.279 | 7.665 | 6.019 | 3.857 | 202.79 | 21.088 | 2.059 | 0.09 | 0.06 | 0 |
| Non-Current Liabilities: | ||||||||||||||||
| Long Term Debt
| 1.936 | 2.022 | 2.357 | 2.5 | 0.013 | 0.053 | 0.091 | 0.129 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.695 | 0.542 | 0.463 | 0.583 | 0.255 | 0.324 | 0.314 | 0.282 | 0.005 | 0.019 | 4.025 | 0.24 | 4.025 | 4.025 | 4.025 | 0 |
| Total Non-Current Liabilities
| 2.631 | 2.564 | 2.82 | 3.083 | 0.268 | 0.377 | 0.405 | 0.411 | 0.005 | 0.019 | 4.025 | 0.24 | 4.025 | 4.025 | 4.025 | 0 |
| Total Liabilities
| 22.712 | 14.846 | 11.731 | 13.049 | 10.577 | 7.511 | 7.685 | 8.077 | 6.024 | 3.876 | 206.815 | 21.327 | 6.084 | 4.115 | 4.085 | 0 |
| Equity: | ||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.072 | 0.072 | 0.072 | 0 | 0 | 0 |
| Common Stock
| 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.005 | 0.005 | 0.005 | 0.005 | 0.001 | 0.039 | 115 | 107.255 | 107.408 | 0 |
| Retained Earnings
| -189.988 | -154.598 | -130.331 | -116.657 | -109.22 | -99.794 | -89.655 | -80.65 | -68.788 | -58.678 | -9.763 | -53.644 | -4.837 | -0.319 | -0.167 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 2.834 | 3.257 | 2.693 | 2.358 | 2.875 | 0.035 | 0.34 | 0.351 | 0.245 | 0.134 | 0.098 | -0.168 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 675.343 | 671.999 | 670.185 | 609.969 | 531.272 | 589.55 | 131.309 | 129.192 | 123.826 | 122.054 | 33.987 | 42.056 | -0.072 | 5.319 | 5.167 | 0 |
| Total Shareholders Equity
| 488.195 | 520.664 | 542.554 | 495.676 | 424.933 | 489.797 | 41.999 | 48.898 | 55.288 | 63.515 | 24.395 | -11.645 | 110.163 | 112.255 | 112.407 | 0 |
| Total Equity
| 495.502 | 530.031 | 552.386 | 513.491 | 489.642 | 499.11 | 59.112 | 68.767 | 82.568 | 94.558 | 24.395 | -11.645 | 110.163 | 112.255 | 112.407 | 0 |
| Total Liabilities & Shareholders Equity
| 518.213 | 544.878 | 564.117 | 526.54 | 500.219 | 506.621 | 66.797 | 76.843 | 88.592 | 98.434 | 231.21 | 9.682 | 116.247 | 116.37 | 116.492 | 0 |